Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease, and NAFLD/NASH (nonalcoholic fatty liver disease) today announced the pricing of its initial public offering. The shares are expected to begin trading on the […]
Serial entrepreneurs are the lifeblood of a vibrant, growing venture capital community, and the Great Lakes Region is home to many successful founders who can translate their past experience into growing new companies in this area. Over the past decade, one Michigan entrepreneur and venture capitalist has proven she has the determination to nurture multiple […]